GeneCentric Announces Series C Financing to Advance Novel Liquid Biopsy Platform for Precision Oncology - Candlesense

GCNT Financing

GeneCentric Announces Series C Financing to Advance Novel Liquid Biopsy Platform for Precision Oncology

Published June 18, 2025 at 12:00 PM

DURHAM, N.C.--(BUSINESS WIRE)-- #GeneCentric--GeneCentric Announces $8 Million Series C Financing to Advance Novel GenomicsNext Liquid Biopsy Platform for Precision Oncology